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Abstract 
 Objective: Evaluate the effect of probiotics association in reducing the 
total bilirubin level in the serum of neonates with jaundice. Methods: 69 
neonates with indirect hyperbilirubinemia were divided randomly into two 
groups: control and treatment. The control group was treated using 
phototherapy and the treatment group was treated using phototherapy plus 
L.Reuteri probiotic. Inclusion criteria: all term newborns admitted for 
phototherapy for unconjugated hyperbilirubinemia. Exclusion criteria: septic 
or ill newborn, phenobarbital therapy, transfusion and parents ‘refusal to enter 
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the study. Baseline bilirubin level was obtained prior to initiating phototherapy 
and then daily for an average of 3 days. Results: Before treatment, the level 
of bilirubin was similar in the two groups (p>0.05). We noted a more 
significant difference in bilirubin at day 1 (p=0.000), day 2 (=0.000) and day 
3 (p=0.000) during treatment in the probiotic group when compared to the 
control group. We also noticed a more significant decrease in bilirubin 
between day 1 and day 2 (p=0.000) and between day 2 and day 3 (p=0.000) in 
the probiotic group when compared to the control group. Conclusion: The 
decrease of bilirubin in neonates with jaundice is more rapid and more 
significant in the group receiving probiotics as an adjuvant to phototherapy in 
case of presence of incompatibility or not. 
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Introduction 
 Jaundice is one of the most commonly encountered symptom during 
the neonatal period. It manifests itself as a yellow pigmentation of the mucosa 
due to an accumulation of bilirubin.(Porter and Dennis 2002) 
 Hyperbilirubinemia in newborns mostly occurs due to high levels of 
unconjugated bilirubin in the blood that can have multiple causes such as 
ABO/Rhesus incompatibility, infections, prematurity, hypothyroidism, 
polyglobulia, G6PD deficiency and metabolic disorders. Even unconjugated 
hyperbilirubinemia is mainly a transitional phenomenon; it may lead to 
irreversible neurological complications known as “kernicterus”. (Alcayd 
2008) (Mutombo et al. 2014) Treatment of jaundice requires the treatment of 
the underlying cause besides the different strategies to decrease serum 
bilirubin.  Phototherapy, intravenous immunoglobulins, and exchange 
transfusion are the most frequently used therapies due to their efficiency and 
efficacy in deceasing serum bilirubin with very few side effects. Other 
therapies include Chinese herbs that activate the hepatic receptor CAR 
(Huang, Zhang, and Moore 2004), Vimala massages which improves 
physiological jaundice by increasing newborn defecation (Seyyedrasooli et al. 
2014)and enzyme inductors like phenobarbital(Crigler and Gold 1969) . 
Recently, probiotics are being  studied for their potential benefit in being an 
adjunctive treatment of indirect hyperbilirubinemia (Wenbin Liu 2015). 
 Probiotics are live microorganisms, which, if given in the right doses, 
can be beneficial to their host. They are known for their ability to promote the 
growth of other microorganisms and to increase the activity of bacteria in the 
intestinal flora. They also play a role in modulating the immune system and 
producing anti-microorganism substances. (Torkaman et al. 2016) (S et al. 
2013) These multiple mechanisms of action of probiotics have made them an 
object of study with regard to many different pathologies in which they have 
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had a proven efficacy, such as in antibiotic-associated diarrhea,(Issa and 
Moucari 2014) necrotizing enterocolitis,(Gogineni, Morrow, and Malesker 
2013) (Chang et al. 2017) (Silverman, Konnikova, and Gerber 2017) allergic 
reactions(Harmsen 2016) (Cuello-Garcia et al. 2015) (Forsberg et al. 2013), 
inflammatory bowel disease(Kwon and Farrell 2003), irritable bowel 
syndrome(Cui and Hu 2012), infantile colic(Mi et al. 2015) (Partty et al. 2015) 
(Roberts, Ostapchuk, and O’Brien 2004) and neonatal jaundice(W., H., and T. 
2015) (Demirel et al. 2013) (Torkaman et al. 2016). 
 In our study, we compared two treatment modalities of neonatal 
jaundice: Exclusive phototherapy versus phototherapy combined with 
L.Reuteri probiotic administration. Our objective was to determine whether 
serum bilirubin decreases more rapidly with the added probiotic, which would 
decrease the duration of hospitalization of newborns with jaundice. 
 
Methods & Statistics 
 69 neonates with jaundice from the NICUs of 3 different centers: UH-
Notre Dame de Secours hospital center, Haykal hospital and Kobayyat 
hospital were selected for the study between June 2016 and July 2017 after 
their parents signed a written consent form. The method of selection was by 
coin tossing. 
 Inclusion criteria were all term newborns admitted for phototherapy 
for indirect hyperbilirubinemia 
 Exclusion criteria were sepsis, newborns receiving IVIG or 
phenobarbital, or those whose parents refused to give consent to the study. 
 The neonates were randomized into two groups: Group 1 (control 
group) included 29 newborns with jaundice who received exclusive 
phototherapy, while group 2 (treatment group) included 40 newborns who 
received phototherapy and an adjuvant probiotic “Bio Gaia” containing 
Lactobacillus Reuteri which was given orally or via bottle once daily ( 100 
million live LR per 5 drops). 
 Venous blood was drawn before treatment and daily during treatment 
to detect serum bilirubin levels. A complete blood workup was also conducted 
in order to determine the cause of jaundice in each case. 
 A form was filled for each child noting their gestational age, birth and 
actual weight, cause of jaundice, age at the time of treatment plus total serum 
bilirubin before and on each day during the treatment. A section was reserved 
at the bottom of the form to report any adverse effects due to the probiotic 
given. 
 
Analysis 
 A statistical analysis was conducted using SPSS version 22 with a 
confidence interval of 95%. Quantitative data was expressed by means and 
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standard deviation while qualitative data was expressed as a percentage. A 
paired T test was used for the comparison of means; p value <0.05 was 
considered significant, p value < 0.01 was considered highly significant, and 
p value of <0.001 was considered extremely significant. 
 Group 1- the control group- consisted of 29 newborns with an initial 
total serum bilirubin varying between 11.9 mg/dl and 24.4 mg/dl with a mean 
duration of hospitalization of 3.62 days. Group 2 – the intervention group- 
consisted of 40 newborns with an initial total serum bilirubin varying between 
11 mg/dl and 24.6 mg/dl and a mean duration of hospitalization of 3.4 days. 
 
Results 
 The mean of the total serum bilirubin (TSB) measured each day in both 
groups was calculated: 
 On day 1, the mean TSB was 15.55 mg/dl in-group 1 and 13.7 mg/dl 
in-group 2. Day 2, the mean TSB was 12.77 mg/dl in-group 1 and 11.7 mg/dl 
in-group 2 .Day 3 the mean TSB was 11.43 mg/dl in-group 1 and 11.5 mg/dl 
in-group 2.  
 A comparison of the difference in the mean of total serum bilirubin 
(TSB) between day 0 and day 1, 2, 3 after treatment was made in each group 
using the paired T test. In the probiotic group, results showed a significant 
drop in total serum bilirubin between day 0 and day 1 (p=0.000), day 0 and 
day 2 (p=0.000) and between day 0 and day 3 (p=0.000). The decrease in the 
TSB was very significant between day 1 and day 2 (p=0.000) and between day 
2 and day 3 (p=0.030) (Table 1). 
Table 1: Variation of the difference in mean TSB in the intervention group. 
 Mean of the difference 
in TSB 
 
Valeur P 
Day 0-Day 1 5.107 0.000 
Day 0-Day 2 7.27 0.000 
Day 0-Day 3 7.27 0.000 
Day 1-Day 2 2.34 0.000 
Day 2-Day 3 1.64 0.030 
Day 3-Day 4  0.825 0.360 
 
 On the other hand, a comparison of the means of total serum bilirubin 
in the control group only showed a significant decrease of the TSB between 
day 0 and day 2 (p=0.022) but no significant decrease has been demonstrated 
between day 0 and day 1 (p=0.157) neither between day 0 and day 3 (p=0.134) 
(Table 2). 
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Table 2: Variation of the difference in mean TSB in the control group 
 Mean of the difference 
in TSB 
P Value  
Day 0-Day 1 1.157 0.157 
Day 0-Day 2 3.36 0.022 
Day 0- Day 3 3.50 0.134 
Day 1- Day 2 1.45 0.137 
Day 2- Day 3 1.41 0.245 
Day 3- Day 4 2.45 0.189 
 
 The duration of hospitalization was not affected by whether the cause 
of hyperbilirubinemia was ABO/Rh incompatibility or not (p=0.28), neither it 
was different when comparing the two groups. 
 
Discussion 
 Neonatal jaundice is a frequent problem of the newborn with various 
etiologies. It requires early treatment to prevent complications and the possible 
accumulation of bilirubin in the white matter of the brain, which leads to 
irreversible neurological sequelae: kernicterus. 
 Phototherapy has been the gold standard treatment of neonatal 
jaundice as it is able to significantly and quickly decrease total serum bilirubin. 
However, long durations of phototherapy as well as using high wave 
intensities can have some undesirable effects in newborns such as 
hyperthermia, erythematous rashes, burns and diarrhea. (Ennever et al. 1987)  
 Probiotics have recently been an object of interest in this regard 
because of their ability to increase excretion of bilirubin and therefore decrease 
neonatal jaundice more rapidly when coupled with phototherapy.(W., H., and 
T. 2015) (Torkaman et al. 2016) (Demirel et al. 2013) 
 They have proven to be very beneficial for intestinal motility and 
integrity and for the modulation of the immune system and have been used in 
studies on newborns with jaundice as an adjuvant to phototherapy, in which 
they have contributed to a quicker and more significant decrease in total serum 
bilirubin with no documented side effects. 
 In Demirel et al’s study in 2012 in Turkey, preterm newborns with 
hyperbilirubinemia were divided into two groups: 
 The control group (98 neonates) received breast milk or formula 
without a probiotic, and the treatment group (81 neonates) received breast milk 
or formula with the probiotic S. boulardii. The obtained results demonstrated 
a significant decrease in the duration of hospitalization in the group receiving 
the probiotic when compared with the control group (1.9 ± 0.86 days in the 
treatment group compared with 2.6 ± 0.9 days in the control group with a p 
value of 0.000).(Demirel et al. 2013) 
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 Liu W. et al in 2015 divided 68 term neonates with jaundice into two 
groups, where the first group received phototherapy along with phenobarbital, 
and the second group received phototherapy with the probiotic “bifid triple 
viable”. The decrease of serum bilirubin was more significant at day 4 
(p=0.002) and day 7 (p=0.001) in the group that received the probiotic.(W., 
H., and T. 2015) 
 In Torkaman M. et al’s study in 2015, the objective was to determine 
the effect of administration of probiotic on the duration of hospitalization. 92 
neonates at term with jaundice were divided into two groups, where the 
treatment group received the probiotic “Prokid” and the control group received 
a placebo. Their results demonstrated a significant decrease in the duration of 
hospitalization (p=0.001) in the treatment group.(Torkaman et al. 2016) 
 Our study showed significant  difference between control and 
intervention groups especially in the first three days of treatment weather 
jaundice is due to incompatibility or not. 
 Although phototherapy has a triple mechanism of action leading to the 
conversion of bilirubin into lamirubin preventing the deposition of bilirubin in 
the tissues, we have demonstrated that the conjunctive use of probiotic L. 
reuteri has an effect of accelerating the intestinal motility and the reabsorption 
of biliary acids in the entero-hepatic circulation thereby accelerating the 
excretion of bilirubin and preventing its toxic accumulation. 
 
Conclusion  
 The treatment of neonatal jaundice has been approached using several 
medical treatments, which have been banned, from the market. This problem 
has encouraged researchers to find new therapies that have the capacity to 
decrease bilirubin with minimal side effects. 
 In our study, we have demonstrated that using a probiotic in 
conjunction with phototherapy can lead to a significant decrease in serum 
bilirubin in newborns, especially during the first two days of treatment. 
However, it did not affect the duration of hospitalization . Larger scale studies 
should be done to determine if these results could be duplicated. 
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